Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | MCBS | MCB |
|---|---|---|
| Price | $34.56 | $87.05 |
| Change today | ▼ 0.86% | ▼ 1.89% |
| Market cap | $994.68M | $1.08B |
| Return, 3 months | -2.0% | -10.7% |
| Return, year to date | +33.6% | +15.0% |
| Return, 1 year | +32.9% | +16.6% |
| P/E (TTM) | 12.0 | 11.1 |
| P/B | 1.8 | 1.1 |
| P/E percentile vs own 5y | 69th | 58th |
| Dividend yield | 3.01% | 0.86% |
| Revenue growth (YoY, latest qtr) | +31.3% | +21.9% |
| Net profit growth (YoY) | +31.5% | +2.4% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | 44.3% | 24.8% |
| Return on equity | 15.9% | 10.2% |
| Analyst target vs. price | +10.0% | +20.6% |
| Analyst buy share | 0% | 50% |
| RSI (14) | 44 | 39 |
| 30-day volatility | 14.4% | 17.0% |
| Max drawdown, 1 year | -13.4% | -18.7% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
